GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,195 Cr | ₹1,635 Cr | ₹2,320 Cr | ₹2,084 Cr | ₹1,698 Cr |
What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹1,195 Cr |
| Mar2024 | ₹1,635 Cr |
| Mar2023 | ₹2,320 Cr |
| Mar2022 | ₹2,084 Cr |
| Mar2021 | ₹1,698 Cr |
How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,195 Cr | -26.89 | |
| Mar2024 | ₹1,635 Cr | -29.53 | |
| Mar2023 | ₹2,320 Cr | 11.32 | |
| Mar2022 | ₹2,084 Cr | 22.75 | |
| Mar2021 | ₹1,698 Cr | - | |
Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,789.1 Cr | 1.5% | -8.4% | 31.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1.5% |
-8.4% |
31.6% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses